EP3391890
PÓSAKÓNAZÓL SAMSETNINGAR SEM ERU LAUSNIR TIL GJAFAR Í BLÁÆÐ STÖÐGAÐAR MEÐ SETNU BETA-SÝKLÓDEXTRÍNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.6.2011EP published:
25.8.2021EP application number:
18171672.1
EP translation filed:
29.10.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
23.6.2031Expiry date:
23.6.2026Next due date:
30.6.2026
Title:
POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN
Timeline
Today
24.6.2011EP application
25.8.2021EP Publication
29.10.2021Translation submitted
15.12.2021Registration published
23.6.2026Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
Heimbecher, Susan, K.Address:
Summit, New Jersey 07901-1330, US
Name:
Monteith, DavidAddress:
Summit, New Jersey 07901-1330, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
359701 PDate:
29.6.2010Country:
US
Classification
Categories:
A61K 31/715, A61K 31/497, A61P 31/00, A61P 31/10, A61K 31/496, A61K 9/00, A61K 31/724, A61K 47/40, A61P 3/06, A61P 7/02, A61P 31/04, A61P 33/00, A61P 33/02, A61P 35/00, A61P 35/02, A61P 35/04, A61P 37/06, A61P 7/04, A61P 31/08, A61P 31/18
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 18.5.2022
Expires: 23.6.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 24.5.2023
Expires: 23.6.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.5.2024
Expires: 23.6.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 30.5.2025
Expires: 23.6.2026
Payer: Árnason Faktor ehf.